StreetInsider.com News Articles

Anika Therapeutics (ANIK) Tops Q2 EPS by 40c

Wed, 29 Jul 2026 07:44:23 -0400

Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.42, $0.40 better than the analyst estimate of $0.02. Revenue for the quarter came in at $32.6 million versus the consensus estimate of $29.21 million.

For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.

Form 8-K Anika Therapeutics, Inc. For: Jul 29

Wed, 29 Jul 2026 07:20:00 -0400

si-local-file:///var/storage/secattach/20260729/26830560.html

Form 8-K Anika Therapeutics, Inc. For: Jul 29

Wed, 29 Jul 2026 07:20:00 -0400

si-local-file:///var/storage/secattach/20260729/26830560.html

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

BEDFORD, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a global leader in the osteoarthritis ("OA") pain management and regenerative solutions spaces focused on early-intervention orthopedics, today announced financial results for the second quarter of 2026.

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Anika Reports Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 07:05:00 -0400

Commercial Channel Revenue Increased 17% to a Record $13.9 Million

Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020

Raising Full-Year 2026 Financial Guidance and Revising 2027 Revenue Forecast

Total revenue for the second quarter was $32.6 million, compared to $28.2 million in the prior-year

Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: BlackRock Portfolio Management LLC

Fri, 17 Jul 2026 11:33:00 -0400

si-local-file:///var/storage/secattach/20260717/26783070.html

Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: BlackRock Portfolio Management LLC

Fri, 17 Jul 2026 11:33:00 -0400

si-local-file:///var/storage/secattach/20260717/26783070.html

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Wed, 15 Jul 2026 16:01:00 -0400

BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.

The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and accompanying presentation materials will be available in

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Wed, 15 Jul 2026 16:01:00 -0400

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Wed, 15 Jul 2026 16:01:00 -0400

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

Wed, 15 Jul 2026 16:01:00 -0400

Form 8-K Anika Therapeutics, Inc. For: Jul 10

Tue, 14 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260714/26768932.html

Form 8-K Anika Therapeutics, Inc. For: Jul 10

Tue, 14 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260714/26768932.html

Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: CONLEY SHERYL L

Tue, 23 Jun 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260623/26679908.html

Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: CONLEY SHERYL L

Tue, 23 Jun 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260623/26679908.html